» Articles » PMID: 18668671

A Systematic Review on the Clinical Diagnosis of Gastrointestinal Stromal Tumors

Overview
Journal J Surg Oncol
Date 2008 Aug 1
PMID 18668671
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this work was to assess the prevalence of symptoms of gastrointestinal stromal tumors (GISTs) and the diagnostic yield of clinical procedures for its diagnosis.

Methods: Medical databases were consulted between 1998 and 2006 for potentially relevant publications. All studies dealing with the clinical presentation of GIST and related diagnostic procedures were included. Two researchers worked independently on the study selection, quality assessment, data extraction, and analysis phases of the study.

Results: Forty-six observational studies were included with a total of 4,534 patients. Gastrointestinal bleeding was the most common clinical presentation. Twenty studies provided adequate information on the diagnostic yield of various procedures. The pooled diagnostic yield of endoscopy + mucosal biopsy and of intestinal contrast radiography was 33.8% (0-100%) and 35.1% (11-100%), respectively, while that of EUS and that of EUS-FNA was 68.7% (40-100%) and 84.0% (73.8-100%), respectively. Abdominal CT scan and MRI had similar pooled diagnostic yields: 73.6% (34.8-100%), and 91.7% (75-100%), respectively.

Conclusion: Endoscopy + mucosal biopsy should be reserved to patients with gastrointestinal bleeding. EUS-FNA provides direct visualization of the neoplasm and adequate samples for molecular diagnosis. EUS, abdominal CT and MRI may be considered valid alternatives whenever EUS-FNA is unavailable or a cytological diagnosis is unnecessary.

Citing Articles

Huge Gastrointestinal Stromal Tumor (GIST) in Upper Gastrointestinal Masquerade Anaemia.

Zahidin M, Singh J, Mohammad Azmi S, Azhar A, Md Hashim M, Zakaria A Cureus. 2024; 16(6):e62409.

PMID: 39011216 PMC: 11247141. DOI: 10.7759/cureus.62409.


Neurofibromatosis Type 1 Presenting as Bleeding Jejunal Gastrointestinal Stromal Tumour.

Liang R, Chau C, Lim W Case Rep Gastroenterol. 2024; 18(1):299-305.

PMID: 38895585 PMC: 11185854. DOI: 10.1159/000538688.


Evaluating nomogram models for predicting survival outcomes in gastric gastrointestinal stromal tumors with SEER database analysis.

Yong L, Li L, Wu J, Liang P, Gao J Sci Rep. 2024; 14(1):11494.

PMID: 38769376 PMC: 11106332. DOI: 10.1038/s41598-024-62353-z.


English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology.

Hirota S, Tateishi U, Nakamoto Y, Yamamoto H, Sakurai S, Kikuchi H Int J Clin Oncol. 2024; 29(6):647-680.

PMID: 38609732 PMC: 11130037. DOI: 10.1007/s10147-024-02488-1.


Outcomes of Patients with Gastrointestinal Stromal Tumors in the Past Decade.

Bangolo A, Fwelo P, Al-Qatish T, Bukasa-Kakamba J, Lee T, Cayago A Med Sci (Basel). 2023; 11(3).

PMID: 37755158 PMC: 10536810. DOI: 10.3390/medsci11030054.